When was DiaSorin founded?

DiaSorin was founded in 1968 and raised its 1st funding round 41 years after it was founded.

Where is DiaSorin located?

DiaSorin is headquartered in Saluggia, Italy. It is registered at Solitaire Corporate Park,Building No. 1,Unit 152, 5th Floor, Andheri Ghatkoper Link Road,C, hakala, Mumbai City, Andheri East, Maharashtra, India, 400093.

How many employees does DiaSorin have?

As of Sep 30, 2026, the latest employee count at DiaSorin is 2881.

Is DiaSorin a funded company?

DiaSorin is a funded company, having raised an undisclosed amount across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 17, 2009.

When was the latest funding round of DiaSorin?

DiaSorin's latest funding was a $***** Grant (prize money) round on Jan 13, 2021, with participation from 1 investor.

Where does DiaSorin rank among its competitors?

DiaSorin ranks 6th amongst 408 active competitors, of which 51 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was FOXO Technologies, which secured $1.65M in Jun, 2025.

Who are the top competitors of DiaSorin?

DiaSorin's top competitors include Roche, Hologic and FOXO Technologies. Among them, FOXO Technologies secured the most recent funding round in June, 2025.

DiaSorin - 2026 Company Profile, Funding & Competitors

DiaSorin is a public company based in Saluggia (Italy), founded in 1968. It operates as a Develops and commercializes reagent kits for in vitro diagnostics. DiaSorin has raised an undisclosed amount in funding. The company has 408 active competitors, including 51 funded and 42 that have exited. Its top competitors include companies like Roche, Hologic and FOXO Technologies.

Company Details

DiaSorin develops and commercializes reagent kits for in vitro diagnostics, specifically for the immunodiagnostics and molecular diagnostics segments. DiaSorin's suite of products are specifically designed for hospital and private testing laboratories, in the fields of infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology.. As of Jan 2016, the company maintains offices in Europe, the United States, Central and South America, Asia and South Africa.

Website: int.diasorin.com/en
Social
Registered Address: Solitaire Corporate Park,Building No. 1,Unit 152, 5th Floor, Andheri Ghatkoper Link Road,C, hakala, Mumbai City, Andheri East, Maharashtra, India, 400093

Key Metrics

Founded Year

1968

Location

Saluggia, Italy

Stage

Public

Latest Funding Round

Grant (prize money), Jan 13, 2021, $*****

Investors

Eiffel Investment Group & 2 more

Ranked

6^th among 408 active competitors

Employee Count

2,881 as on Sep 30, 2026

Investment & Acquisitions

Luminex & 1 more

Similar Companies

Roche & 291 more

Exit Details

Public

View DiaSorin's full profile

DiaSorin is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DIASORIN HEALTHCARE INDIA PRIVATE LIMITED CIN: U85100MH2012FTC323879 , India, Active	Jul 10, 2012	₹50 - ₹100 Cr (As on Mar 31, 2025)	-

DiaSorin has raised funding over 5 rounds. Its first funding round was on Mar 17, 2009. Its latest funding round was a Grant (prize money) round on Jan 13, 2021 for $*****. 1 investor participated in its latest round. DiaSorin has 3 institutional investors.

Here is the list of recent funding rounds of DiaSorin:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 13, 2021	6232556	Grant (prize money)	2694222	2348607	1766333	1208246
Dec 30, 2020	1041402	Grant (prize money)	4658222	8126600	1290402	Public Health Emergency
Nov 17, 2020	3077431	Grant (prize money)	2698106	7416183	8851402	Public Health Emergency

Access funding benchmarks and valuations. Sign up today!

View details of DiaSorin's funding rounds and investors

DiaSorin's employee count trend

DiaSorin has 2,881 employees as of Sep 26. Here is DiaSorin's employee count trend over the years:

Uncover DiaSorin's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DiaSorin include Roche, Hologic and FOXO Technologies. Here is the list of Top 10 competitors of DiaSorin, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
2nd	Hologic 1985, Marlborough (United States), Acquired	Manufacturer of medical diagnostic devices and systems for women health	-	Saints Capital, Triodos Investment Management ... & 3 others	61/100
3rd	FOXO Technologies 2020, Minneapolis (United States), Public	Provider of epigenetic diagnostic services alongside rural and behavioral hospitals	$40M	Bespoke Growth Partners, Inc., Centrecourt Asset Management ... Read more	60/100
4th	NVision Imaging Technologies 2015, Ulm (Germany), Series A	Provider of medical imaging by quantum technologies	$35M	Playground Global, Kreissparkasse Esslingen Nurtingen ... & 8 others	56/100
5th	Hangzhou Deshi Biotechnology 2016, Hangzhou (China), Public	Devices for HPV virus detection & RNA detection	$30.2M	Xiangjiang Liyuan Investment, Shenzhen Guozhong Venture Capital Management ... & 8 others	56/100
6th	DiaSorin 1968, Saluggia (Italy), Public	Develops and commercializes reagent kits for in vitro diagnostics	-	Eiffel Investment Group, Public Health Emergency ... & 1 others	56/100
7th	numares 2004, Regensburg (Germany), Series B	Developer of diagnostic tests using metabolomics and nuclear magnetic resonance spectroscopy	$26.8M	Bayern Kapital, Kfw & 2 others	55/100
8th	Sysmex 1968, Kobe (Japan), Public	Developer of diagnostic instruments, reagents, and related software	-	-	55/100
9th	EKF 1990, Penarth (United Kingdom), Public	Develops point-of-care and laboratory blood analyzers	$179K	Octopus Investments, IBG Beteiligungsgesellschaft Sachsen-Anhalt ... & 2 others	53/100
10th	SonoSite 1986, Bothell (United States), Acquired	Point-of-care ultrasound solutions provider, empowering clinicians with advanced imaging	-	Europa	52/100